Buparlisib. Phosphatidylinositol 3-kinase alpha inhibitor, Oncolytic.

Citation:
Azab, F., B. Muz, P. de la Puente, and A. - K. Salama, N and Azab, "Buparlisib. Phosphatidylinositol 3-kinase alpha inhibitor, Oncolytic.", Drugs of the Future , vol. 38, issue 2, pp. 73-79, 2013.
PreviewAttachmentSize
noha_nabi_salama-__2013.pdf144.26 KB